Active drug (BIIB014) at 10, 30, 100, or 300 mg once daily. ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	1

6. パーキンソン病

---

臨床試験数 : 2,307 /  薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00451815 (ClinicalTrials.gov)	January 2003	31/1/2006	BIIB014 Phase 2a Monotherapy	A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of Multiple Oral Dose Administration of BIIB014 in Subjects With Early Parkinson’s Disease	Parkinson's Disease	Drug: active drug (BIIB014) at 10, 30, 100, or 300 mg once daily.;Drug: placebo	Biogen Idec	NULL	Withdrawn	30 Years	78 Years	Both		Phase 2	NULL